Overview

The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients

Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The proposed study is a pilot study and a first step towards developing an optimized HPV vaccination strategy for girls who have CKD, or are on dialysis or have a kidney transplant.
Details
Lead Sponsor:
Indiana University
Collaborators:
Merck Sharp & Dohme Corp.
National Kidney Foundation
Treatments:
Vaccines